Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.91
0.00 (0.00%)
At close: Aug 18, 2025, 3:59 PM
1.94
1.57%
After-hours: Aug 18, 2025, 05:19 PM EDT
Spero Therapeutics Revenue
Spero Therapeutics reported an annual revenue of $27.4M, reflecting a -71.68% growth. For the quarter ending June 30, 2025, Spero Therapeutics generated $11.8M in revenue.
Revenue (ttm)
27.4M
Revenue Growth
-71.68%
Price / Sales Ratio
2.03
Revenue / Employee
856.13K
Employees
32
Market Cap
107.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 27.4M | -71.68% |
| Dec 31, 2023 | 96.73M | +99.13% |
| Dec 31, 2022 | 48.58M | +166.10% |
| Dec 31, 2021 | 18.26M | +95.67% |
| Dec 31, 2020 | 9.33M | +96.75% |
| Dec 31, 2019 | 4.74M | +19.57% |
| Dec 31, 2018 | 3.97M | +100.40% |
| Dec 31, 2017 | 1.98M | +490.75% |
| Dec 31, 2016 | 335K | +Infinity% |
| Dec 31, 2015 | 0 | n/a |